DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.

Doris Lambracht-Washington, Bao Xi Qu, Min Fu, Larry D. Anderson, Olaf Stüve, Todd N. Eagar, Roger N. Rosenberg

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Medicine & Life Sciences